Balanced news tone
News Sentiment
CPIX sentiment intelligence
Cumberland Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
74/100 classification confidence.
directly relevant articles
high-authority source matches
-6.9% over one week, +5.9% over four weeks, trend active, and materially above fair value.
Cumberland Pharmaceuticals declares $1.50 special dividend, $5M buyback after $100M Apotex deal
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Cumberland Pharmaceuticals Inc (CPIX) Financial Health: Profitability & Balance Sheet Analysis
Cumberland Pharmaceuticals Inc (CPIX) has a financial score of 7.48, ranking 114 out of 157 in the Pharmaceuticals industry, indicating stable financial status and high operating efficiency. Despite this, its latest quarterly revenue decreased by 22.04% year-over-year, and its ne
- Tone
- Negative 40/100
- Event
- Earnings
- Published
- 18 Jun 2026 17:40
- Source
- TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Institutional Confidence
This article analyzes the institutional confidence score for Cumberland Pharmaceuticals Inc (CPIX), which currently stands at 3.00, ranking 94th in the Pharmaceuticals industry. Institutional shareholding proportion decreased by 30.06% quarter-over-quarter, with James Simons iden
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 05:39
- Source
- TradingKey
Cumberland Pharmaceuticals, Vanderbilt Health Report Positive Phase 2a Results for Ifetroban in Metastasis Prevention Study
- Tone
- Positive 58/100
- Event
- Earnings
- Published
- 02 Jun 2026 13:51
- Source
- MT Newswires
Cumberland Pharmaceuticals (CPIX) Rises 2.84%: Support Holds as Stock Approaches Resistance - Trend Following Picks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- dars.gov.et
Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 May 2026 07:00
- Source
- Ad Hoc News
Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Market source
Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- PR Newswire
Cumberland Pharmaceuticals sells drug portfolio for $100M to Canadian giant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- The Business Journals
Cumberland Pharmaceuticals jumps on $100M Apotex transaction
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Market source
Cumberland takes $100M cash deal, keeps three Phase II programs
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Apr 2026 07:00
- Source
- Stock Titan
Cumberland Pharmaceuticals (CPIX) jumps on $100 million Apotex asset-sale deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Apr 2026 07:00
- Source
- Quiver Quantitative
Little Excitement Around Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Revenues As Shares Take 31% Pounding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- simplywall.st
Cumberland Pharmaceuticals Leads 3 Promising Penny Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Dec 2025 08:00
- Source
- Market source
Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Dec 2025 08:00
- Source
- Market source